Mr. Chair, many contracts we have currently are based on the advance purchase agreement. They are with different vaccine manufacturers. The details are with our colleagues in PSPC, but just as a reminder, these are evolving scenarios, with bivalent vaccines coming on board too. We continue to move to obtain those specific vaccines, which are current and which we can use on the Canadian population.
On February 6th, 2023. See this statement in context.